NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email With U.S. tariffs still weighing on Canada’s steel and aluminum sectors, a Quebec-based food can manufacturer is expanding its operations — and bringing the American portion of its supply chain back home.Read More